Institutional investors purchased a net $1.1 million shares of VICL during the quarter ended March 2014, and now own 38.53% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LMR PARTNERS LLP Bought 164.4 Thousand shares of Vical Inc
MEDICAL STRATEGY GMBH Sold 44.0 Thousand shares of Vical Inc
OXFORD ASSET MANAGEMENT LLP Sold 62.2 Thousand shares of Vical Inc